Plexxikon
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Plexxikon sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Plexxikon: 6 sponsored US clinical trials, none currently recruiting.
Plexxikon sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rheumatoid Arthritis, with 1 trials.
Upper-quartile sponsor footprint
Plexxikon sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
A Study of PLX51107 in Advanced Malignancies
NCT02683395
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
NCT02673736
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
NCT01804530
Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate
NCT01329991
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult Volunteers
NCT01282684
Safety Study of PLX4032 in Patients With Solid Tumors
NCT00405587
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
Therapeutic Areas
How the Plexxikon early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 3 completed (50%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Rheumatoid Arthritis (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Plexxikon: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Plexxikon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Plexxikon page
6 registered trials is a research-attention snapshot, not an endorsement of Plexxikon or any single study.
- None of Plexxikon's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Rheumatoid Arthritis is the condition Plexxikon studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Plexxikon pipeline card: 6 registered trials from official public datasets.Report a data error.